Collectively, these results suggest that therapeutic strategies targeting PCSK9, correcting vitamin D deficiency, and promoting smoking cessation may provide clinically meaningful benefits for improving cardiometabolic and reproductive outcomes in women with PCOS. Here, PCSK9 is linked to polycystic ovary syndrome.